NO323707B1 - Anvendelse av Ginkgo biloba ekstrakter for fremstilling av et medikament. - Google Patents

Anvendelse av Ginkgo biloba ekstrakter for fremstilling av et medikament. Download PDF

Info

Publication number
NO323707B1
NO323707B1 NO20002775A NO20002775A NO323707B1 NO 323707 B1 NO323707 B1 NO 323707B1 NO 20002775 A NO20002775 A NO 20002775A NO 20002775 A NO20002775 A NO 20002775A NO 323707 B1 NO323707 B1 NO 323707B1
Authority
NO
Norway
Prior art keywords
residue
ginkgo biloba
ginkgolide
use according
compound
Prior art date
Application number
NO20002775A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002775L (no
NO20002775D0 (no
Inventor
Katy Drieu
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO20002775D0 publication Critical patent/NO20002775D0/no
Publication of NO20002775L publication Critical patent/NO20002775L/no
Publication of NO323707B1 publication Critical patent/NO323707B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
NO20002775A 1997-12-03 2000-05-30 Anvendelse av Ginkgo biloba ekstrakter for fremstilling av et medikament. NO323707B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9715230A FR2771639B1 (fr) 1997-12-03 1997-12-03 Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a faciliter le sevrage d'individus dependants de la consommation d'une substance engendrant une dependance et/ou une addiction
PCT/FR1998/002576 WO1999027943A1 (fr) 1997-12-03 1998-12-01 Utilisation d'extraits de ginkgo biloba pour preparer un medicament

Publications (3)

Publication Number Publication Date
NO20002775D0 NO20002775D0 (no) 2000-05-30
NO20002775L NO20002775L (no) 2000-06-02
NO323707B1 true NO323707B1 (no) 2007-06-25

Family

ID=9514108

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002775A NO323707B1 (no) 1997-12-03 2000-05-30 Anvendelse av Ginkgo biloba ekstrakter for fremstilling av et medikament.

Country Status (21)

Country Link
US (2) US6936285B1 (cs)
EP (1) EP1035858B1 (cs)
JP (1) JP2001524528A (cs)
KR (1) KR100597139B1 (cs)
CN (1) CN1188141C (cs)
AT (1) ATE216587T1 (cs)
AU (1) AU749752B2 (cs)
CA (1) CA2312856C (cs)
CZ (1) CZ299427B6 (cs)
DE (1) DE69805096T2 (cs)
DK (1) DK1035858T3 (cs)
ES (1) ES2177097T3 (cs)
FR (1) FR2771639B1 (cs)
HU (1) HUP0100223A3 (cs)
IL (1) IL136304A0 (cs)
NO (1) NO323707B1 (cs)
NZ (1) NZ505516A (cs)
PL (1) PL190849B1 (cs)
PT (1) PT1035858E (cs)
RU (1) RU2207140C2 (cs)
WO (1) WO1999027943A1 (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827518B1 (fr) * 2001-07-17 2005-07-08 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie
KR20030080623A (ko) * 2002-04-09 2003-10-17 주식회사 바이오메딕스 금연을 돕는 조성물 및 제조방법
US7169704B2 (en) 2002-06-21 2007-01-30 Samsung Electronics Co., Ltd. Method of cleaning a surface of a water in connection with forming a barrier layer of a semiconductor device
US20080038198A1 (en) * 2004-01-05 2008-02-14 Mitsubishi Pharma Corporation Method Of Screening Molecule Associated With Psychiatric Disorder
US20090099102A1 (en) * 2005-10-27 2009-04-16 The Brigham And Women's Hospital, Inc. Ginkgolides in the Treatment and Prevention of Ovarian Cancer
DE102005062417A1 (de) * 2005-12-27 2007-08-23 Korth, Ruth-Maria, Dr.med. Kompositionen mit spezifischen und unspezifischen Lipidantagonisten
US11039997B2 (en) 2005-12-27 2021-06-22 Ruth-Maria Korth Cosmetic, dermatic, protective compositions comprising phospholipids, lecithins with peptides and at least one acetylating compound
RU2406488C1 (ru) * 2009-04-20 2010-12-20 Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии Сибирского отделения РАМН Нейропротекторное средство
US20120171282A1 (en) * 2009-07-28 2012-07-05 Velleja Research S.R.L. Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders
CN101946784B (zh) * 2010-09-26 2013-04-03 云南省农业科学院生物技术与种质资源研究所 银杏内酯b在制备抗烟草花叶病毒药物中的应用
CN112089772B (zh) * 2020-09-15 2022-02-18 汉济生物科技（武汉）有限公司 一种药物组合物及其在制备戒毒药物中的应用
CN113144021B (zh) * 2021-05-21 2022-08-19 常州工业职业技术学院 一种戒毒用中药组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8725871D0 (en) * 1987-11-04 1987-12-09 Scras Ginkgolide derivatives
DE3940094A1 (de) * 1989-12-04 1991-06-06 Montana Ltd Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel
DE3940091A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE3940092A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE4008046C2 (de) * 1990-03-14 1999-09-16 Irbit Research & Consulting Ag Verfahren zur Herstellung eines Formteils aus Melaminharzschaumstoff
JP2924099B2 (ja) * 1990-06-13 1999-07-26 茂 川瀬 経口節煙剤
JP3188461B2 (ja) * 1991-12-23 2001-07-16 ドクター・ビィルマール・シュバーベ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・カンパニー 緊張及び不安の処置のためのビロバリドを含有する医薬製剤
JP3181356B2 (ja) * 1992-03-25 2001-07-03 ダイセル化学工業株式会社 中枢神経作用薬
DE4317868C2 (de) * 1993-05-28 1996-04-18 Arrowdean Ltd Neuartiges Anxiolytikum
JPH0753371A (ja) * 1993-08-11 1995-02-28 Daicel Chem Ind Ltd 抗痙攣薬
KR0136986B1 (ko) * 1993-12-31 1998-04-25 김준웅 신규 징코라이드 유도체와 이의 제조방법
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
US5976548A (en) * 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
GB9508533D0 (en) * 1995-04-27 1995-06-14 Sod Conseils Rech Applic Flavonoid extract of ginkgo biloba as flavouring and/or texturing agent

Also Published As

Publication number Publication date
NO20002775L (no) 2000-06-02
EP1035858A1 (fr) 2000-09-20
PT1035858E (pt) 2002-10-31
ATE216587T1 (de) 2002-05-15
CA2312856A1 (fr) 1999-06-10
FR2771639B1 (fr) 2000-05-05
PL190849B1 (pl) 2006-02-28
ES2177097T3 (es) 2002-12-01
FR2771639A1 (fr) 1999-06-04
RU2207140C2 (ru) 2003-06-27
IL136304A0 (en) 2001-05-20
DK1035858T3 (da) 2002-08-19
CZ299427B6 (cs) 2008-07-23
WO1999027943A1 (fr) 1999-06-10
CN1188141C (zh) 2005-02-09
CA2312856C (fr) 2009-04-07
EP1035858B1 (fr) 2002-04-24
DE69805096D1 (de) 2002-05-29
CZ20002007A3 (cs) 2000-11-15
AU1438099A (en) 1999-06-16
US20040180105A1 (en) 2004-09-16
HUP0100223A3 (en) 2004-05-28
DE69805096T2 (de) 2002-11-14
KR20010032716A (ko) 2001-04-25
JP2001524528A (ja) 2001-12-04
PL340794A1 (en) 2001-02-26
CN1280499A (zh) 2001-01-17
US6936285B1 (en) 2005-08-30
NO20002775D0 (no) 2000-05-30
NZ505516A (en) 2001-10-26
HUP0100223A2 (hu) 2001-10-28
KR100597139B1 (ko) 2006-07-06
AU749752B2 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
DE69837551T2 (de) Zusammensetzung und verfahren zur behandlung der alzheimer'schen krankheit und anderen amyloidosen
DE69525847T2 (de) Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
NO323707B1 (no) Anvendelse av Ginkgo biloba ekstrakter for fremstilling av et medikament.
Osadebe et al. Hypoglycemic activity of the extract and fractions of Anthocleista vogelii (Planch) stem bark
US6524629B1 (en) Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis
CA2352005A1 (en) Extracts, compounds & pharmaceutical compositions having anti-diabetic activity and their use
WO2005003145A1 (en) Shanzhuyu extract and uses thereof
Bone Echinacea: what makes it work
Agam et al. High-dose peripheral inositol raises brain inositol levels and reverses behavioral effects of inositol depletion by lithium
Osigwe et al. Antihyperglycemic studies on the leaf extract and active fractions of Newbouldia laevis (Bignoniaceae)
Kim et al. Panax ginseng blocks morphine-induced thymic apoptosis by lowering plasma corticosterone level
Lu et al. Preventive effect of the Taiwan folk medicine Ixeris laevigata var. oldhami on α‐naphthyl‐isothiocyanate and carbon tetrachloride‐induced acute liver injury in rats
KR19990014692A (ko) 알콜탐익을 치료하기 위한 약제학적 조성물
EP1503771B1 (en) Sedative materials and treatments
WO1997035598A1 (en) Pharmaceutical compositions and methods for the manufacture thereof
IE930485A1 (en) Antidepressant agents with a rapid onset of action
US10350253B2 (en) Use of american ginseng to counteract cannabis-induced intoxication
WO2011135011A1 (en) Treatment of cartilage resorption
Ahmad et al. Biochemical evaluation and hypoglycemic activity of ethanolic extract of Xanthium strumarium L. on normoglycemic and alloxan-induced diabetic mice
JPH0459733A (ja) 蛇床子抽出・精製物を有効成分とするストレスによる機能障害改善剤
DE60113569T2 (de) Verwendung von cumarin oder seines hydroxy-derivats zur behandlung von mittelschwerem oder schwerem gefäss- und/oder lymphödem
US20130079295A1 (en) Treatment of cartilage resorption
HK1009096B (en) Pharmaceutical compositions for the treatment of alcohol addiction

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees